Tekmira Receives $14.5 Million Milestone Payment
January 21, 2014 at 07:16 AM EST
Tekmira Pharmaceuticals (Nasdaq: TKMR ) confirmed today that it has received US$14.5 million of the net US$16.5 million in near term payments as outlined in the terms of an option agreement signed with Monsanto, which supports the application of Tekmira's proprietary delivery technology and related intellectual property (IP) for
